Cargando…

Hepatitis E Virus: An emerging enigmatic and underestimated pathogen

Hepatitis E virus (HEV) is an RNA virus causing hepatitis E disease. The virus is of one serotype but has diverse genotypes infecting both humans and animals. Based on evidence from seroprevalence studies, about 2 billion people are estimated to have been infected with HEV globally. HEV, therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Raji, Yakubu Egigogo, Toung, Ooi Peck, Taib, Niazlin Mohd, Sekawi, Zamberi Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716866/
https://www.ncbi.nlm.nih.gov/pubmed/35002446
http://dx.doi.org/10.1016/j.sjbs.2021.09.003
_version_ 1784624409950027776
author Raji, Yakubu Egigogo
Toung, Ooi Peck
Taib, Niazlin Mohd
Sekawi, Zamberi Bin
author_facet Raji, Yakubu Egigogo
Toung, Ooi Peck
Taib, Niazlin Mohd
Sekawi, Zamberi Bin
author_sort Raji, Yakubu Egigogo
collection PubMed
description Hepatitis E virus (HEV) is an RNA virus causing hepatitis E disease. The virus is of one serotype but has diverse genotypes infecting both humans and animals. Based on evidence from seroprevalence studies, about 2 billion people are estimated to have been infected with HEV globally. HEV, therefore, poses a significant public health and economic challenge worldwide. HEV was discovered in the 1980s and was traced back to the 1955 – 1956 outbreak of hepatitis that occurred in India. Subsequently, several HEV epidemics involving thousands of individuals have occurred nearly annually in different countries in Asia and Africa. Initially, the virus was thought to be only enterically transmitted, and endemic in developing countries. Due to the environmental hygiene and sanitation challenges in those parts of the world. However, recent studies have suggested otherwise with the report of autochthonous cases in industrialised countries with no history of travel to the so-called endemic countries. Thus, suggesting that HEV has a global distribution with endemicity in both developing and industrialised nations. Studies have also revealed that HEV has multiple risk factors, and modes of transmission as well as zoonotic potentials. Additionally, recent findings have shown that HEV leads to severe disease, particularly among pregnant women. In contrast to the previous narration of a strictly mild and self-limiting infection. Studies have likewise demonstrated chronic HEV infection among immunocompromised persons. Consequent to these recent discoveries, this pathogen is considered a re – emerging virus, particularly in the developed nations. However, despite the growing public health challenges of this pathogen, the burden is still underestimated. The underestimation is often attributed to poor awareness among clinicians and a lack of routine checks for the disease in the hospitals. Thus, leading to misdiagnosis and underdiagnosis. Hence, this review provides a concise overview of epidemiology, diagnosis, and prevention of hepatitis E.
format Online
Article
Text
id pubmed-8716866
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87168662022-01-06 Hepatitis E Virus: An emerging enigmatic and underestimated pathogen Raji, Yakubu Egigogo Toung, Ooi Peck Taib, Niazlin Mohd Sekawi, Zamberi Bin Saudi J Biol Sci Article Hepatitis E virus (HEV) is an RNA virus causing hepatitis E disease. The virus is of one serotype but has diverse genotypes infecting both humans and animals. Based on evidence from seroprevalence studies, about 2 billion people are estimated to have been infected with HEV globally. HEV, therefore, poses a significant public health and economic challenge worldwide. HEV was discovered in the 1980s and was traced back to the 1955 – 1956 outbreak of hepatitis that occurred in India. Subsequently, several HEV epidemics involving thousands of individuals have occurred nearly annually in different countries in Asia and Africa. Initially, the virus was thought to be only enterically transmitted, and endemic in developing countries. Due to the environmental hygiene and sanitation challenges in those parts of the world. However, recent studies have suggested otherwise with the report of autochthonous cases in industrialised countries with no history of travel to the so-called endemic countries. Thus, suggesting that HEV has a global distribution with endemicity in both developing and industrialised nations. Studies have also revealed that HEV has multiple risk factors, and modes of transmission as well as zoonotic potentials. Additionally, recent findings have shown that HEV leads to severe disease, particularly among pregnant women. In contrast to the previous narration of a strictly mild and self-limiting infection. Studies have likewise demonstrated chronic HEV infection among immunocompromised persons. Consequent to these recent discoveries, this pathogen is considered a re – emerging virus, particularly in the developed nations. However, despite the growing public health challenges of this pathogen, the burden is still underestimated. The underestimation is often attributed to poor awareness among clinicians and a lack of routine checks for the disease in the hospitals. Thus, leading to misdiagnosis and underdiagnosis. Hence, this review provides a concise overview of epidemiology, diagnosis, and prevention of hepatitis E. Elsevier 2022-01 2021-09-20 /pmc/articles/PMC8716866/ /pubmed/35002446 http://dx.doi.org/10.1016/j.sjbs.2021.09.003 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Raji, Yakubu Egigogo
Toung, Ooi Peck
Taib, Niazlin Mohd
Sekawi, Zamberi Bin
Hepatitis E Virus: An emerging enigmatic and underestimated pathogen
title Hepatitis E Virus: An emerging enigmatic and underestimated pathogen
title_full Hepatitis E Virus: An emerging enigmatic and underestimated pathogen
title_fullStr Hepatitis E Virus: An emerging enigmatic and underestimated pathogen
title_full_unstemmed Hepatitis E Virus: An emerging enigmatic and underestimated pathogen
title_short Hepatitis E Virus: An emerging enigmatic and underestimated pathogen
title_sort hepatitis e virus: an emerging enigmatic and underestimated pathogen
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716866/
https://www.ncbi.nlm.nih.gov/pubmed/35002446
http://dx.doi.org/10.1016/j.sjbs.2021.09.003
work_keys_str_mv AT rajiyakubuegigogo hepatitisevirusanemergingenigmaticandunderestimatedpathogen
AT toungooipeck hepatitisevirusanemergingenigmaticandunderestimatedpathogen
AT taibniazlinmohd hepatitisevirusanemergingenigmaticandunderestimatedpathogen
AT sekawizamberibin hepatitisevirusanemergingenigmaticandunderestimatedpathogen